Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHP640 in Adenoviral Conjunctivitis
NCT02998541Phase 3Terminated
- Sponsor
- Takeda
- Start
- Mar 2017
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 3 trial of dexamethasone + povidone-iodine in adenoviral conjunctivitis, sponsored by Takeda. Started Mar 2017; status: terminated.
02
Drugs
dexamethasone + povidone-iodine
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on NCT02998541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998541.